Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-25

Clinical Trial Update: Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis Infection [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous pertussis immune globulin in children with severe pertussis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous Pertussis Immune Globulin (pertussis immune globulin, intravenous)

Snippet

Sponsor: IWK Health Centre | Conditions: Pertussis, Whooping Cough | Phase 3 | Status: COMPLETED